Bayer unit tagged with $289 million Roundup cancer verdict

Bayer subsidiary Monsanto faces a $289 million jury verdict over its weedkiller Roundup, which has been linked to cancer. A jury in California found in favor of a retired school groundskeeper who used Roundup as a pesticide for decades. The dying man discovered tumors all over his body, and was diagnosed with in cancer in… Read More

Smith & Nephew Hip Implant Lawsuits Expand

Smith & Nephew Hip Implant Lawsuits Expand

R3 metal liners added to Birmingham Hip Resurfacing litigation A panel of federal judges overseeing hundreds of lawsuits against Smith & Nephew for their failed metal on metal hip devices is expanding the scope of the litigation. The United States Judicial Panel on Multidistrict litigation held that plaintiffs implanted with the recalled R3 metal liner… Read More

MRI risks detailed in new warning for Gadolinium

Gadolinium, a contrast agent used in MRI scans, is the target of a new health warning issued for patients and healthcare providers. The warnings are being added to the medication guide and patient materials for certain MRI, or magnetic resonance imaging tests. Top officials at Bayer, GE, Bracco Diagnostics and Guerbet signed off on the… Read More

Onglyza heart failure lawsuits expand

Onglyza diabetes drug lawsuits are growing in federal court, with the number of claims recently passing the 100 mark. The pharmaceutical legal team at Jones Ward is playing a leading role in these cases. Alex Davis, one of the firm’s partners, filed one of the first Onglyza heart failure lawsuits in federal court in 2016.… Read More

Smith & Nephew hip implant lawsuits expand

The hip implant recall lawyers at Jones Ward are expanding the scope of a legal challenge to the Smith & Nephew BHR, targeting a configuration of the device that never gained FDA approval. Smith & Nephew faces approximately 300 individual lawsuits in federal court from patients who claim that the BHR failed and shed toxic… Read More

Onglyza heart failure MDL sent to Kentucky

Heart failure lawsuits tied to diabetes drugs Onglyza and Kombiglyze XR will be consolidated in Kentucky federal court, a panel of judges has decided. Ongylza and Kombiglyze XR are used by more than 100,00 Type 2 Diabetes patients in the U.S., and both drugs have been on the U.S. market since at least 2010. But it… Read More